Pharmacology and pharmacokinetics of methotrexate in rheumatic disease. Practical issues in treatment and design

Rheumatic Disease Clinics of North America

Volumn 23, Issue 4, 1997, Pages 757-778

  Hillson, J L ^a   Furst, D E ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID ANTAGONIST; METHOTREXATE;

CHEMICAL STRUCTURE; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG METABOLISM; DRUG TOXICITY; IMMUNOREGULATION; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; STRUCTURE ACTIVITY RELATION;

EID: 0030716459     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70359-8     Document Type: Article

References (131)

1. G.W. Ahern E. Piall V. Marks Prolongation and enhancement of serum methotrexate concentrations by probenecid Br Med J 1 1978 1097
2. S. Ahmad F.H. Shen W.A. Bleyer Methotrexate-induced renal failure and ineffectiveness of peritoneal dialysis Arch Intern Med 138 1978 1146
3. C.J. Allegra B.A. Chabner J.C. Drake Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates J Biol Chem 260 1985 9720
4. C.J. Allegra J.C. Drake J. Jolivet Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates Proc Natl Acad Sci 82 1985 4881
5. Anaya J.-M. D. Fabre F. Bressolle Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis J Rheumatol 21 1994 203
6. J.E. Baggott S.L. Morgan W.H. Vaughn Differences in methotrexate and 7-OH-methotrexate inhibition of folate-dependent enzymes of purine nucleotide biosynthesis Biochem J 300 1994 627
7. J.E. Baggott W.H. Vaughn B.B. Hudson Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide Biochem J 236 1986 193
8. M. Balinska J. Galivan J.K. Coward Efflux of methotrexate and its polyglutamate derivatives from hepatic cells in vitro Cancer Res 41 1981 2751
9. F.M. Ballis J.L. Savitch W.A. Bleyer Pharmacokinetics of oral methotrexate in children Cancer Res 42 1983 2342
10. C.M. Baugh C.L. Krumdieck M.G. Nair Polygammaglutamyl metabolites of methotrexate Biochem Biophys Res Commun 52 1973 27
11. R.A. Bender W.A. Bleyer S.A. Frisby V.T. Oliverio Alteration of methotrexate uptake in human leukemia cells by other agents Cancer Res 35 1975 1305
12. J.M. Berthelot Y. Maugars M. Hamidou Pancytopenia and severe cytopenia induced by low-dose methotrexate. Eight case-reports and a review of one hundred cases from the literature (with twenty-four deaths) Rev Rhum Engl Ed 62 1995 477
13. W.A. Bleyer The clinical pharmacology of methotrexate. New applications of an old drug Cancer 41 1978 36
14. P. Calabresi B.A. Chabner Antineoplastic agents A.G. Goodman T.W. Rall Nies A.S. The Pharmacological Basis of Therapeutics 1990 Pergamon New York 1223
15. A.H. Calvert P.K. Bondy K.P. Harrap Some observations on the human pharmacology of methotrexate Cancer Treat Rev 61 1977 1647
16. B.A. Chabner R.C. Young Threshold methotrexate concentrations for in vivo inhibition of DNA synthesis in normal and tumorous target tissues J Clin Invest 52 1973 1804
17. S. Charache P.T. Condit S.R. Humphreys Studies on the folic acid vitamins. IV. The persistence of amethopterin in mammalian tissues Cancer 13 1960 236
18. S.L. Charland D. Bartlett M.H. Torosian Effect of protein-calorie malnutrition on methotrexate pharmacokinetics JPEN J Parenter Enteral Nutr 18 1994 45
19. R. Cimaz F. Corona M. Scarazatti Methotrexate treatment every other week in patients with juvenile chronic rheumatoid arthritis [letter] Br J Rheumatol 35 1995 1030
20. B. Combe L. Edno P. Lafforgue Total and free methotrexate pharmacokinetics, with and without piroxicam, in rheumatoid arthritis patients Br J Rheumatol 34 1995 421
21. A.W. Craft A. Rankin W. Aherne Methotrexate absorption in children with acute lymphoblastic leukemia Cancer Treat Rep 65 Suppl 1 1981 65
22. J.J. Cream D.S. Poole The effect of methotrexate and hydroxyurea on neutrophil chemotaxis Br J Dermatol 102 1980 557
23. B.N. Cronstein The antirheumatic agents sulphasalazine and methotrexate share an anti-inflammatory mechanism Br J Rheumatol 34 Suppl 2 1995 30
24. B.N. Cronstein D. Naime E. Ostad The anti-inflammatory mechanism of methotrexate: Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation J Clin Invest 92 1993 2675
25. M.G.C. Dahl M.M. Gregory P.J. Scheuer Methotrexate hepatotoxicity in psoriasis— comparison of different dose regimens Br Med J 1 1972 654
26. H.M. Daly G.L. Scott J. Boyle C.J.C. Roberts Methotrexate toxicity precipitated by azapropazone Br J Dermatol 114 1986 733
27. L.M. DeAngelis W.P. Tong S. Lin Carboxypeptidase G2 rescue after high dose methotrexate J Clin Oncol 14 1996 2145
28. B.A.C. Dijkmans Folate supplementation and methotrexate Br J Rheumatol 34 1995 1172
29. L.L. Dupuis G. Koren E.D. Silverman R.M. Laxer Influence of food on the bioavailability of oral methotrexate in children J Rheumatol 22 1995 1570
30. J. Edelman D.F. Biggs F. Jamil A.S. Russel Low dose methotrexate kinetics in arthritis Clin Pharmacol Ther 35 1984 382
31. L. Edno F. Bressolle R. Gomeni Total and free methotrexate pharmacokinetics in rheumatoid arthritis patients Ther Drug Monit 18 1996 128
32. R. Ertmann G. Landbeck Effect of oral cholestyramine on elimination of high-dose methotrexate Cancer Treat Rev 61 1977 1647
33. G. Fabre I.D. Goldman Formation of 7-OH-MTX polyglutamyl derivatives and their cytotoxicity in human chronic myelogenous leukemia cells, in vitro Cancer Res 45 1985 80
34. D. Farquhar T.L. Loo S. Vadlamundi Synthesis and biologic evaluation of 7-OH-MTX, 7-methylaminopterin, and 7-methylmethotrexate J Med Chem 15 1972 567
35. J.R. Fountain D.J. Hutchison G.B. Waring Persistence of amethopterin in normal mouse tissues Proc Soc Exp Biol Med 83 1953 369
36. D. Frappaz E. Bouffet P. Cochat Hemoperfusion sur charbon active et hemodialyse dans l'intoxocation aigue au methtresate Presse Med 17 1988 1209
37. M.L. Frenia K.S. Long Methotrexate and nonsteroidal antiinflammatory drug interactions Ann Pharmacother 26 1992 235
38. D.W. Fry J.C. Yalowich I.D. Goldman Rapid formation of poly-γ-glutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high pressure liquid chromatography in the Ehrlich ascites tumor cell in vitro J Biol Chem 257 1982 1890
39. D.E. Furst R.A. Herman R. Koehnke Effect of aspirin and sulindac on methotrexate clearance J Pharm Sci 79 1990 782
40. D.E. Furst R. Koehnke L.F. Burmeister Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis J Rheumatol 16 1989 313
41. D.E. Furst R. Koehnke C. Riggs Prospective, longitudinal study of liver biopsies in 40 RA patients on MTX, followed for 6.5 years Arthritis Rheum 36 Suppl 1993 S39
42. S. Gabriel E. Creagan W.M. O'Fallon Treatment of rheumatoid arthritis with higher dose intravenous methotrexate J Rheumatol 17 1990 460
43. A. Gabrielli P. Leoni G. Danieli Methotrexate and NSAID [letter] Br Med J 204 1987 76
44. J. Galivan Evidence for the cytotoxic activity of polyglutamate derivatives of methotrexate Molec Pharmacol 17 1980 105
45. J.H. Goldie L.A. Price K.R. Harrap Methotrexate toxicity: Correlation with duration of administration, plasma levels, dose and excretion pattern Eur J Cancer 8 1972 409
46. H. Groenendal F.H.J. Rampen Methotrexate and trimethoprim-sulfamethoxazole—a potentially hazardous combination Clin Exp Dermatol 15 1990 358
47. K. Gumbhir-Shah W.H. Cevallos S.A. DeCleene Lack of interaction between bromfenac and methotrexate in patients with rheumatoid arthritis J Rheumatol 23 1996 984
48. C.J. Haagsma P.L.C.M. Van Riel deRooij D.J.R.A.M. Combination of methotrexate and sulphasalazine vs. methotrexate alone: A randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy Br J Rheumatol 33 1994 1049
49. R.A. Hamilton J.M. Kremer The effects of food on methotrexate absorption J Rheumatol 22 1995 630
50. J. Hendel H. Brodthagen Enterohepatic cycling of methotrexate estimated by the use of the d -isomer as a reference marker Eur J Clin Pharmacol 26 1984 103
51. R.A. Herman P. Veng-Pedersen J. Hoffman Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients J Pharm Sci 78 1989 165
52. B.T. Hill B.D. Bailey J.C. White I.D. Goldman Characteristics of transport of 4-amino antifolates and folate compounds in two lines of lymphoblasts Cancer Res 39 1979 2440
53. R.S. Hillman Hematopoietic agents A.G. Goodman T.W. Rall Nies A.S. The Pharmacological Basis of Therapeutics 1990 Pergamon New York 1302
54. A.V. Hoffbrand E. Tripp A. Lavoie Folate polyglutamate synthesis and breakdown in cells Folic Acids: Proceedings of a workshop on human folate requirements 1977 National Academy of Sciences Washington, DC 110
55. S.B. Howell H.E. Blair J. Uren Frei E. Jr Hemodialysis and enzymatic cleavage of methotrexate in man Eur J Cancer 14 1978 787
56. M. Hum B.A. Kamen Successful carboxypeptidase G2 rescue in delayed MTX elimination due to renal failure Pediatr Hematol Oncol 12 1995 521
57. S.A. Jacobs R.H. Adamson B.A. Chabner Stoichiometric inhibition of mammaliam dihydrofolate reductase by the gamma-glutamyl metabolites of methotrexate Biochem Biophys Res Comm 63 1975 692
58. S.A. Jacobs C.J. Derr D.G. Johns Accumulation of methotrexate diglutamate in human liver during methotrexate therapy Biochem Pharmacol 26 1977 2310
59. R. Janknegt N.J. Nube van den Hoogenzand F. Pharmacokinetics of methotrexate in continuous ambulatory peritoneal dialysis Pharm Weekblad 10 1988 86
60. M.E. Jeurosen A.M. Boerbooms van de Putte L.B. Pancytopenia with methotrexate and trimethoprim-sulfamethoxasole [letter] Ann Intern Med 111 1989 261
61. C.A. Johnston A.S. Russell T. Kovithavongs M. Dasgupta Measures of immunologic and inflammatory responses in vitro in rheumatoid patients treated with methotrexate J Rheumatol 13 1986 294
62. J. Jolivet B.A. Chabner Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells: Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate and 4-NH2-10-CH3-pteroylglutamate to dihydrofolate reductase J Clin Invest 72 1983 773
63. J. Jolivet K.H. Cowan G.A. Curt The pharmacology and clinical use of methotrexate N Engl J Med 309 1983 1094
64. J. Jolivet R.L. Schilsky B.D. Bailey Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cells J Clin Invest 70 1982 351
65. J.W. Jundt B.A. Browne G.P. Fiocco A comparison of low dose methotrexate bioavailability: Oral solution, oral tablet, subcutaneous and intramuscular dosing J Rheumatol 20 1993 1845
66. B.A. Kamen M.T. Wang A.J. Streckfull Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles J Biol Chem 263 1988 13602
67. R.L. Kisliuk Y. Gaumont C.M. Baugh Polyglutamyl derivatives of folate as substrates and inhibitors of thymidylate synthetase J Biol Chem 249 1974 4100
68. G.D. Kozloski J.M. DeVito J.C. Kisicki The effect of food on the absorption of methotrexate sodium tablets in healthy volunteers Arthritis Rheum 35 1992 761
69. A. Kraus D. Alarcon-Segovia Low dose MTX and NSAID induced “mild” renal insufficiency and severe neutropenia [letter] J Rheumatol 18 1991 1274
70. J.M. Kremer Possible mechanisms of action of methotrexate in patients with rheumatoid arthritis Br J Rheumatol 34 Suppl 2 1995 26
71. J.M. Kremer J.M.S. Davies R.I. Rynes Every-other-week methotrexate in patients with rheumatoid arthritis: A double-blind, placebo-controlled prospective study Arthritis Rheum 38 1995 601
72. J. Kremer J. Galivan A. Streckfuss Methotrexate analysis in blood and liver of rheumatoid arthritis patients: Association with hepatic folate deficiency and the formation of pyroglutamate Arthritis Rheum 29 1986 832
73. J.M. Kremer J. Galivan A. Streckfuss Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients Arthritis Rheum 29 1986 832
74. J.M. Kremer R.A. Hamilton The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: Impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg J Rheumatol 22 1995 2072
75. J.M. Kremer G.F. Petrillo R.A. Hamilton Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: Association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy J Rheumatol 22 1995 38
76. P. Lafforgue S. Monjanel-Mouterde A. Durand Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? A pharmacokinetic study in 33 patients J Rheumatol 20 1993 263
77. J.H. Lewis E. Schiff Methotrexate-induced chronic liver injury: Guidelines for detection and prevention Am J Gastroenterol 83 1988 1337
78. D.G. Liegler E.S. Henderson M.A. Hahn The effect of organic acids on renal clearance of methotrexate in man Clin Pharmacol Ther 10 1969 849
79. M.B. Lilly G.A. Omura Clinical pharmacology of oral intermediate-dose methotrexate with or without probenecid Cancer Chemother Pharmacol 15 1985 220
80. A.G. Maiche Acute renal failure due to concomitant action of methotrexate and indomethacin [letter] Lancet 1 1986 1390
81. M.A. Mandel The synergistic effect of salicylates on methotrexate toxicity Plast Reconstr Surg 57 1976 733
82. E. Masson M.V. Relling T.W. Synold Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo J Clin Invest 97 1996 73
83. L.H. Matherly C.K. Barlowe V.M. Phillips The effects of 4-aminoantifolates on 5-formyltetrahydrofolate metabolism in L1210 cells J Biol Chem 262 1987 710
84. J.J. McGuire J.L.R. Bertino Enzymatic synthesis and function of folylpolyglutamates Mol Cell Biochem 38 1981 19
85. G.H. Millward-Sadler T.J. Ryan Methotrexate induced liver disease in psoriasis Br J Dermatol 90 1974 661
86. R.G. Moran M. Mulkins C. Heidelberger Role of thymidylate synthetase activity in development of methotrexate cytotoxicity Proc Natl Acad Sci USA 76 1979 5924
87. S.L. Morgan J.E. Baggott G.S. Alarcon Methotrexate and sulfasalazine combination therapy: Is it worth the risk? Arthritis Rheum 36 1993 281
88. G. Nesher T.G. Osborn T.L. Moore In vitro effects of methotrexate on polyamine levels in lymphocytes from rheumatoid arthritis patients Clin Exp Rheum 14 1996 395
89. H.W.K. Ng A.W. Macfarlane R.M. Graham J.L. Verbov Near fatal drug interactions with methotrexate given for psoriasis [letter] Br Med J 295 1987 752
90. B. Nuernberg R. Koehnke M. Solsky Biliary elimination of low-dose methotrexates in humans Arthritis Rheum 33 1990 898
91. D. Oguey F. Koelliker N.J. Gerber Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis Arthritis Rheum 35 1992 611
92. J.L. Olsen L.M. Murray Antiproliferative effects of methotrexate on peripheral blood mononuclear cells Arthritis Rheum 32 1986 378
93. M.J. Osborn M. Freeman Huennekens Inhibition of dihydrofolate reductase by aminopterin and amethopterin Proc Soc Exp Biol 97 1958 429
94. M.J. Phelen W. Taylor van Heyningen C. Intestinal absorption in patients with rheumatoid arthritis treated with methotrexate Clin Rheumatol 12 1993 223
95. C.R. Pinkerton J.F. Glasgow S.G. Welshman J.M. Bridges Can food influence the absorption of methotrexate in children with acute lymphoblastic leukemia? Lancet 944 1980 6
96. A. Ravelli Di Fuccia G. M. Molinaro Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritis J Rheumatol 20 1993 1573
97. T.W. Rooney D.E. Furst R. Koehnke Aspirin is not associated with more toxicity than other nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis treated with methotrexate J Rheumatol 20 1993 1297
98. I. Rosenberg Absorption and malabsorption of folates Clin Haematol 5 1976 589
99. D.S. Rosenblatt V.M. Whitehead M.M. DuPont Synthesis of methotrexate polyglutamates in cultured human cells Molec Pharmacol 29 1980 2701
100. D.R. Seeger D.B. Cosalich J.M. Smith M.E. Hultquist Analogs of pteroylglutamic acid. II. 4-Aminoderivatives J Am Chem Soc 71 1949 1753
101. P. Seideman Methotrexate—the relationship between dose and clinical effect Br J Rheumatol 32 1993 751
102. P. Seideman O. Beck S. Eksborg The pharmacokinetics of methotrexate and its 7-hydroxy metabolite in patients with rheumatoid arthritis Br J Clin Pharmacol 35 1993 409
103. P. Seideman Mueller-Suur E. Ekman Renal effects of low dose methotrexate in rheumatoid arthritis J Rheumatol 20 1993 1126
104. J. Selhub G.J. Dhar I.H. Rosenberg Gastrointestinal absorption of folates and antifolates Pharmacol Ther 20 1983 397
105. J.B. Shiroky Unsubstantiated “risk” of antifolate toxicity in combination methotrexate and sulfasalazine therapy [letter] Arthritis Rheum 36 1993 1757
106. J. Shiroky C. Allegra G. Inghirami High dose intravenous methotrexate with leucovorin rescue in rheumatoid arthritis J Rheumatol 15 1988 251
107. J. Shiroky C. Neville J.D. Skelton High dose intravenous methotrexate for refractory rheumatoid arthritis J Rheumatol 19 1992 247
108. E.E. Sierra K.E. Brigle M.J. Spinella pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells Biochem Pharmacol 53 1997 223
109. R.R. Singh A.N. Malaviya J.N. Pandey J.S. Guleria Fatal interaction between methotrexate and naproxen [letter] Lancet 1 1986 1390
110. M.J. Sinnett G.D. Groff D.A. Raddatz Methotrexate pharmacokinetics in patients with rheumatoid arthritis J Rheumatol 16 1989 745
111. K.J. Skeith A.S. Russell J. Fakreddin Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis J Rheumatol 17 1990 1008
112. P. Sonneveld F.W. Schultz K. Nooter Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in plasma and bone marrow of children receiving low-dose oral methotrexate Cancer Chemother Pharmacol 18 1986 111
113. C.F. Stewart R.A. Fleming C.R. Arkin Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis Clin Pharmacol Ther 47 1990 540
114. C.F. Stewart R.A. Fleming B.F. Germain Aspirin alters methotrexate disposition in rheumatoid arthritis patients Arthritis Rheum 34 1991 1514
115. T.W. Synold M.V. Relling J.M. Boyett Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy and methotrexate dose in acute lymphoblastic leukemia J Clin Invest 94 1994 1996
116. J.R. Taylor K.M. Halprin Effect of sodium salicylate and indomethacin on methotrexate-serum albumin binding Arch Dermatol 113 1977 588
117. D.R. Thomas J.S. Dover R.D.R. Camp Pancytopenia induced by the interaction between methotrexate and trimethoprim-sulfamethoxazole [letter] J Am Acad Dermatol 17 1987 1055
118. M.H. Thomas L.A. Gutterman Methotrexate toxicity in a patient receiving trimethoprim-sulfamethoxazole J Rheumatol 13 1986 440
119. A. Thyss G. Milano M. Kubar M. Schneider Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen Lancet 1 1986 256
120. T.S. Tracy K. Krohn D.R. Jones The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis Eur J Clin Pharmacol 42 1992 121
121. T.T. Tracy T. Worster J.D. Bradley Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis Br J Clin Pharmacol 37 1994 453
122. S.M. Wall M.J. Johansen D.A. Molony Effective clearance of methotrexate using high-flux hemodialysis membranes Am J Kidney Dis 28 1996 846
123. C.A. Wallace W.A. Bleyer D.D. Sherry Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis Arthritis Rheum 32 1989 677
124. R.D. Warren A.P. Nichols R.A. Bender Membrane transport of methotrexate in human lymphoblastoid cells Cancer Res 38 1978 668
125. V.M. Whitehead Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells Cancer Res 37 1977 408
126. V.M. Whitehead M.M. Perrault S. Stelcner Tissue-specific synthesis of methotrexate polyglutamates in the rat Cancer Res 35 1975 2985
127. B.C. Widemann M.L. Hetherington R.F. Murphy Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity Cancer 76 1995 521
128. A. Witte V.M. Whitehead D.S. Rosenblatt Synthesis of methotrexate polyglutamates by bone marrow cells from patients with leukemia and lymphoma Dev Pharmacol Ther 1 1980 40
129. R.F. Zager S.A. Frisby V.T. Oliverio The effects of antibiotics and cancer chemotherapeutic agents on the cellular transport and antitumor activity of methotrexate in L1210 murine leukemia Cancer Res 33 1973 1670
130. D.S. Zaharko W.-P. Fung Yang K.-H. Relative biochemical aspects of low and high doses of methotrexate in mice Cancer Res 37 1977 1602
131. A. Zoubek H.A. Zaunschirm T. Lion Successful carboxypeptidase G2 rescue in delayed methotrexate elimination due to renal failure Pediatr Hematol Oncol 12 1995 4711